Hypothermia Clinical Trial
Official title:
Efficacy of Head and Torso Rewarming by Using a Human Model for Severe Hypothermia
This Clinical trial is being conducted to study the effectiveness of heat donation through head or torso in hypothermic rewarming efficacy using a human model for severe hypothermia. The purpose of the study is to compare the core rewarming effectiveness of the same amount of heat donation through the head or torso in treatment of hypothermia using a human model for severe hypothermia. The information obtained from this study will give a better understanding of heat-transfer mechanisms. This might help in the ongoing research in hypothermia treatment.
Procedure:
Eight healthy, non-pregnant participants between 18 and 45 years old will be cooled in 8°C
water, for 60 minutes or to a core temperature of 35ºC on three occasions and then warmed by
each of three warming conditions.
The study will include following specific procedures:
Anthropometric data which includes age, weight, height, and measurements of skinfold
thickness at four sites- biceps, triceps, subscapularis, and suprailiac will be collected.
Participant's heart rate and electrocardiogram will be monitored continuously throughout the
experiment.
Conditions: The three treatment methods are as follows. A. Spontaneous rewarming (Shivering
inhibition) In this control condition, Demerol will be infused through the arm or hand vein.
The first 1.5 mg/kg will be slowly injected in five equal doses (of 0.3 mg/kg) at 2 minute
intervals during the last 10 minutes of cold water immersion. After removal from the water,
further aliquots of 0.3 mg/kg (at minimum of 2-minute intervals) will be given only as
necessary to inhibit any shivering that may develop, to a maximum cumulative dose of 3.2
mg/kg body weight.
After towel drying the subject will lie on a mattress under an insulated cover without any
extra heating modality. Spontaneous rewarming will be the first condition for every subject,
the results will be used to determine the dosage schedule for demerol in the active warming
conditions below.
B. Head warming:
Charcoal Heater applied to the Head (CH-H) - A charcoal heater (HEATPAC Personal Heater,
Emergco Tech. Solutions, Vancouver) consists of a combustion chamber, a canister containing
the charcoal fuel, and a branched heating duct that produces 250 W of heat. The canister is
placed inside the combustion chamber and the charcoal fuel is ignited. Heated air is blown
through the impermeable heating ducts by a fan within the charcoal heater above the
combustion chamber. The combustion chamber will be placed on right side of the face/head with
ducts wrapping around the dorsum of the head, anteriorly over the forehead, nose, chin and
the neck, not covering the eyes or the mouth. The participant will be breathing ambient air
(̴ 22˚C).
C. Torso warming:
Charcoal Heater to the Torso (CH-T) - The same charcoal heater as above will be used. The
combustion chamber will be placed on the subject's anterior chest with a towel in between.
The flexible ducts will be applied to the areas of high heat transfer i.e. over the
shoulders, neck, and then anteriorly under the axillae to cross over the lower anterior
chest. Participant will be breathing ambient air at room temperature (~22˚C).
Rewarming procedures will be administered either for a period of 60 minutes or until core
temperature returns to normal values ( ̴ 36.5-37˚C). Following that, participants will be
placed in a warm water bath (40-42˚C) until they wish to exit or core temperature reaches
37°C.
Research Design:
Each of the three experimental trials will be separated by at least 48 hours. On each of the
three trials, participants will be immersed up to the level of the sternal notch in 8˚C for
up to 60 minutes or until the core temperature falls to 35˚C. Demerol will be administered by
a licensed physician during the final 10 minutes of immersion to suppress shivering.
Participants will then exit the water, be dried off and rewarmed with either head or torso
warming techniques. After removal from the water, an extra dosage of demerol might be given
to suppress shivering only if its necessary. The rewarming will be administered for 120
minutes or until the core temperature returns to normal values (̴36.5-37˚C). The order of
warming methods will follow a modified balanced design with control being first and the two
active warming conditions being balanced.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05669313 -
The Effects of Hypothermia and Acidosis on Coagulation During Treatment With Rivaroxaban Measured With ROTEM
|
||
Not yet recruiting |
NCT05306392 -
Effects of Induced Moderate Hypothermia on ARDS Patients Under Venovenous ExtraCorporeal Membrane Oxygenation
|
N/A | |
Completed |
NCT02586974 -
Effects of Warmed, Humidified CO2 Insufflation on Body Core Temperature and Cytokine Response
|
N/A | |
Withdrawn |
NCT02812069 -
WarmSmart Warming Protocol
|
N/A | |
Not yet recruiting |
NCT02211703 -
National Epidemiologic Survey on the Incidence of Perioperative Hypothermia
|
N/A | |
Completed |
NCT02742818 -
Forced-air Warming in Endovascular Surgery: Testing Effectiveness of Two Different Blanket Models
|
N/A | |
Completed |
NCT02177903 -
Study to Determine the Effects of Pre-warming on OR Patient Temperatures and Surgical Outcomes
|
N/A | |
Completed |
NCT02121574 -
Accuracy of Zero-flux and Ingestible Thermometers
|
N/A | |
Recruiting |
NCT01866384 -
Targeted Temperature Management After Intracerebral Hemorrhage
|
Phase 2 | |
Active, not recruiting |
NCT01529658 -
Renal Hypothermia During Partial Nephrectomy
|
N/A | |
Completed |
NCT01793337 -
Core Body Temperature Measurement During Hot and Cold Environmental Exposure
|
N/A | |
Completed |
NCT01722955 -
Pre-warmed Intravenous Fluids and Monitored Anesthesia Care
|
N/A | |
Completed |
NCT01559675 -
Trial Comparing Low Dose and High Dose Steroids in Patients Undergoing Colorectal Surgery
|
N/A | |
Terminated |
NCT01018576 -
Delayed Cord Clamping in Premature Infants
|
N/A | |
Completed |
NCT00904228 -
Plastic Hat Trial to Prevent Hypothermia in Preterm Newborns in the Delivery Room
|
N/A | |
Terminated |
NCT00822796 -
Thermogard™ Efficacy Trial
|
N/A | |
Completed |
NCT00334360 -
Dexmed/Buspirone Synergism on Shivering
|
Phase 4 | |
Not yet recruiting |
NCT06283771 -
The Effect of Heated Socks Developed With Wearable Technology on Hypothermia, Thermal Comfort Perception and Shivering
|
N/A | |
Completed |
NCT04399902 -
Study to Actively Warm Trauma Patients
|
N/A | |
Completed |
NCT03450668 -
mOm Incubator Pilot Study
|
N/A |